Maintenance of niaid specific pathogen-free macaque breeding colonies
Ended Awarded Last action
- Contract number
- 75N93023F00001
- Awardee
-
Alpha Genesis Inc. UEI H7E8FHEF7ND5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,803,424
Award facts
- Contract value 100% obligated
- $6,803,424.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition after exclusion of sources Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Yemassee, SC, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $755,233 | |
| Funding Only Action | $204,000 | |
| Funding Only Action | $209,392 | |
| Funding Only Action | $240,000 | |
| Original award | $5,394,799 |
About this award
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Alpha Genesis Inc. The contract is for the maintenance of NIAID's specific pathogen-free macaque breeding colonies. The contract is a cost-plus-fixed-fee delivery order with a total ceiling value of $6,803,424.00 and a period of performance through September 29, 2024. Alpha Genesis Inc. is a for-profit organization and Subchapter S Corporation that provides nonhuman primate products and biomedical research services. The contract does not have a set-aside designation. Alpha Genesis Inc. has previously provided nonhuman primates and related services to support infectious disease and vaccine research programs across various federal agencies.
Quick answers
Who was awarded contract 75N93023F00001?
75N93023F00001 was awarded to Alpha Genesis Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 30, 2017.
How much is contract 75N93023F00001 worth?
The government has obligated $6,803,424 on 75N93023F00001.
Is contract 75N93023F00001 an order under another contract?
Yes. 75N93023F00001 is a delivery order under HHSN272201700046I, an indefinite delivery contract.
Was contract 75N93023F00001 competed?
The extent of competition for 75N93023F00001 was full and open competition after exclusion of sources.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award